{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:45:21Z","timestamp":1790430321846,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"23-24","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bmcl.2018.10.028","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T12:07:28Z","timestamp":1540210048000},"page":"3689-3692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro"],"prefix":"10.1016","volume":"28","author":[{"given":"Federica","family":"Ferrigno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Biancofiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savina","family":"Malancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ponzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Paonessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Graziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bresciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalise","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Summa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus M.","family":"Ontoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2018.10.028_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001859","volume":"6","author":"Simarro","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmcl.2018.10.028_b0010","unstructured":"http:\/\/www.who.int\/trypanosomiasis_african\/country\/en\/."},{"key":"10.1016\/j.bmcl.2018.10.028_h0015","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2174\/1568026616666160413125335","volume":"16","author":"Grewal","year":"2016","journal-title":"Curr Top Med Chem."},{"key":"10.1016\/j.bmcl.2018.10.028_h0020","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","volume":"390","author":"B\u00fcscher","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.bmcl.2018.10.028_h0025","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/522982","volume":"45","author":"Priotto","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.bmcl.2018.10.028_h0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2018.10.028_h0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cid\/cis886","volume":"56","author":"Alirol","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.bmcl.2018.10.028_h0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pt.2018.04.002","volume":"34","author":"Fairlamb","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bmcl.2018.10.028_h0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.trstmh.2005.03.017","volume":"100","author":"P\u00e9pin","year":"2006","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1016\/j.bmcl.2018.10.028_h0050","doi-asserted-by":"crossref","first-page":"e1695","DOI":"10.1371\/journal.pntd.0001695","volume":"6","author":"Kuepfer","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmcl.2018.10.028_h0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","volume":"15","author":"Field","year":"2017","journal-title":"Nat Rev Microbiol."},{"key":"10.1016\/j.bmcl.2018.10.028_h0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006504","volume":"12","author":"Kazumba","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmcl.2018.10.028_h0065","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1586\/14787210.2014.959496","volume":"12","author":"Eperon","year":"2014","journal-title":"Expert Rev Anti Infect Ther."},{"key":"10.1016\/j.bmcl.2018.10.028_b0035","unstructured":"T. brucei initial screening campaign was run at the Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland (marcel.kaiser@swisstph.ch)."},{"key":"10.1016\/j.bmcl.2018.10.028_h0075","doi-asserted-by":"crossref","first-page":"e1600347","DOI":"10.1002\/ardp.201600347","volume":"350","author":"Alves Avelar","year":"2017","journal-title":"Arch Pharm Chem Life Sci."},{"key":"10.1016\/j.bmcl.2018.10.028_h0080","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1021\/acs.jmedchem.6b01595","volume":"60","author":"Hailu","year":"2017","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2018.10.028_b0045","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/acsmedchemlett.5b00468","volume":"7","author":"Ontoria","year":"2016","journal-title":"ACS Med Chem Lett."},{"key":"10.1016\/j.bmcl.2018.10.028_b0050","unstructured":"All data showed in Tables 1 and 2 were generated internally."},{"key":"10.1016\/j.bmcl.2018.10.028_b0055","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1021\/jm800079s","volume":"51","author":"Jones","year":"2008","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2018.10.028_h0100","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/jo202652f","volume":"77","author":"Davis","year":"2012","journal-title":"J Org Chem."},{"key":"10.1016\/j.bmcl.2018.10.028_h0105","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1021\/ol902910w","volume":"12","author":"Davis","year":"2010","journal-title":"Org Lett."},{"key":"10.1016\/j.bmcl.2018.10.028_b0065","unstructured":"For the preparation of the compounds 2, 28, 29, 30, 31 and 32 refer to WO2018\/115275."},{"key":"10.1016\/j.bmcl.2018.10.028_b0070","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1365-2958.2007.06079.x","volume":"67","author":"Siegel","year":"2008","journal-title":"Mol Microbiol."},{"key":"10.1016\/j.bmcl.2018.10.028_h0120","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1128\/AAC.00364-08","volume":"52","author":"Ojo","year":"2008","journal-title":"Antimicrobial Agents Chemother."},{"key":"10.1016\/j.bmcl.2018.10.028_h0125","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/cmdc.201300072","volume":"8","author":"Woodland","year":"2013","journal-title":"Chem Med Chem."},{"key":"10.1016\/j.bmcl.2018.10.028_h0130","first-page":"34","volume":"F70","author":"Timm","year":"2014","journal-title":"Acta Cryst."},{"key":"10.1016\/j.bmcl.2018.10.028_h0135","doi-asserted-by":"crossref","first-page":"e1164","DOI":"10.1371\/journal.pntd.0001164","volume":"5","author":"Kuettel","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmcl.2018.10.028_h0140","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1371\/journal.pntd.0000506","volume":"3","author":"Kuettel","year":"2009","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmcl.2018.10.028_h0145","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1074\/jbc.M511504200","volume":"281","author":"Tu","year":"2006","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bmcl.2018.10.028_h0150","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1039\/C4MD00045E","volume":"5","author":"Patel","year":"2014","journal-title":"Med Chem Comm."},{"key":"10.1016\/j.bmcl.2018.10.028_h0155","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/cmdc.200900262","volume":"4","author":"Spinks","year":"2009","journal-title":"Chem Med Chem."},{"key":"10.1016\/j.bmcl.2018.10.028_h0160","doi-asserted-by":"crossref","first-page":"27456","DOI":"10.1074\/jbc.M113.495101","volume":"288","author":"Lu","year":"2013","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bmcl.2018.10.028_b0095","unstructured":"TbGSK-3 assay was run in Prof. Wesley Van Vooorhis Laboratory, University of Washington, Seattle, United States (wesley@uw.edu); TbAK assay was run in PD Dr. Remo Perozzo laboratory, University of Geneva, Switzerland (Remo.Perozzo@unige.ch); TbAUK-1 assay was run in Prof. Larry Ruben, Southern Methodist University, Seattle, United States (lruben@mail.smu.edu); TbTR assay was run internally."},{"key":"10.1016\/j.bmcl.2018.10.028_b0100","unstructured":"Other known enzymatic targets of T. brucei inhibitors against which our compounds were not tested are for instance T. brucei farnesyl protein transferase (TbFPT), phosphodiesterase B1 (TbPDEB1), catepsin B (TbcatB) and N-myristoyltranserase (TbNMT); Jacobs RT, Nare B, Phillips MA. Curr. Top. Med. Chem. 2011;11:1255\u20131274; Gilbert IH. Parasitology 2014;141:28\u201336."},{"key":"10.1016\/j.bmcl.2018.10.028_b0105","unstructured":"T. cruzi assay was run at the Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland (marcel.kaiser@swisstph.ch); P. falciparum assay was run internally."},{"key":"10.1016\/j.bmcl.2018.10.028_h0180","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1021\/jm9004303","volume":"52","author":"Kinzel","year":"2009","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2018.10.028_h0185","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/00498250903082279","volume":"39","author":"Fonsi","year":"2009","journal-title":"Xenobiotica"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18308308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18308308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:27:11Z","timestamp":1760772431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X18308308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":37,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0960894X18308308"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.10.028","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}